cardiovascularКардиоваскулярная терапия и профилактикаCardiovascular Therapy and Prevention1728-88002619-0125«SILICEA-POLIGRAF» LLCcardiovascular-904Research ArticleАРТЕРИАЛЬНАЯ ГИПЕРТОНИЯARTERIAL HYPERTENSIONВлияние фиксированной комбинации периндоприла и индапамида на ремоделирование сердца и сосудов у пациентов с артериальной гипертониейInfluence of fixed combination perindopril and indapamide on heart and vascular remodeling in hypertensive patientsЛопатинЮ. М.LopatinYu. M.zuzuk67@mail.ruКаплановТ. Д.КаplanovT. D.zuzuk67@mail.ruИваненкоВ. В.IvanenkoV. V.zuzuk67@mail.ruРязанцеваН. В.RyazantsevaN. V.zuzuk67@mail.ruЛегкийА. В.LegkyA. V.zuzuk67@mail.ruАнисимоваЛ. П.AnisimovaL. P.zuzuk67@mail.ruВолгоградский государственный медицинский университет, ВолгоградVolgograd State Medical University, VolgogradВолгоградский областной кардиологический центр, ВолгоградVolgograd Regional Cardiology Center, Volgograd200520022005412025Copyright © Лопатин Ю.М., Капланов Т.Д., Иваненко В.В., Рязанцева Н.В., Легкий А.В., Анисимова Л.П., 20052005Лопатин Ю.М., Капланов Т.Д., Иваненко В.В., Рязанцева Н.В., Легкий А.В., Анисимова Л.П.Lopatin Y.M., Каplanov T.D., Ivanenko V.V., Ryazantseva N.V., Legky A.V., Anisimova L.P.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://cardiovascular.elpub.ru/jour/article/view/904

Aim. To evaluate antihypertensive efficacy of fixed combination: perindopril 4 mg/d plus indapamide 1.25 mg/d, and its influence on cardiovascular remodeling in untreated hypertensive patients. Material and methods. The study included 25 previously untreated patients with arterial hypertension (mean age 48.1±2,7 years; 13 males, 12 females). The effects of 6-month perindopril/indapamide combined therapy on daily blood pressure (BP), left ventricular (LV) hypertrophy, carotid intima-media thickness (IMT), pulse wave velocity (PWV), and cerebral blood flow velocity were investigated. Results. Target BP level was achieved in 77% of the patients. BP monitoring demonstrated significant reduction in systolic BP (daytime: -9.4%, p<0.001; nighttime: -10.4%, p<0.001) and diastolic BP (-10.6%, p<0,001; -9.9%, p<0.001, respectively). Substantial reduction of LV mass index (-12%, p=0.005) was observed. LV posterior wall and interventricular septal thickness were reduced by 7.6% (p<0.004) and 9.5% (p=0.001), respectively. Carotid IMT decrease (-12.1%, p<0.001) and arterial stiffness reduction in elastic arteries (carotid-femoral PWV decreased by 11.3%, p=0.0001) were registered. Cerebral blood flow velocity, normal at baseline, did not change. Conclusion. Treatment with a fixed combination of perindopril and indapamide in hypertensive patients is characterized by high antihypertensive efficacy, metabolic neutrality, and positive influence on remodeling of both the heart and large and medium arteries. 

артериальная гипертонияфиксированная комбинация периндоприла/индапамидасердечно-сосудистое ремоделированиеarterial hypertensionfixed perindopril/indapamide combinationcardiovascular remodelingReferencesGuidelines Committee. 2003 European Society of Hypertension – European Society of cardiology Guidelines for the management of Arterial Hypertension. J Hypertens 2003; 21: 1011-53.Guidelines Committee. 2003 European Society of Hypertension – European Society of cardiology Guidelines for the management of Arterial Hypertension. J Hypertens 2003; 21: 1011-53.Второй пересмотр рекомендаций ВНОК по профилактике, диагностике и лечению артериальной гипертензии. Кардиоваск тер профил 2004; 3(3), ч. I: 105-20.Второй пересмотр рекомендаций ВНОК по профилактике, диагностике и лечению артериальной гипертензии. Кардиоваск тер профил 2004; 3(3), ч. I: 105-20.Chanudet X, Phong Chau N, De Champvallins M. Very low-dose perindopril 2 mg/indapamide 0,625 mg combination gives higher response and normalization rates than losartan 50 mg in the treatment of essential hypertension. Am J Hypertens 2000; 4: 140A.Chanudet X, Phong Chau N, De Champvallins M. Very low-dose perindopril 2 mg/indapamide 0,625 mg combination gives higher response and normalization rates than losartan 50 mg in the treatment of essential hypertension. Am J Hypertens 2000; 4: 140A.Morgan T, Anderson A. Low dose combination therapy (perindopril, indapamide) compared with irbesartan monotherapy. J Hypertens 2001; 19 (Suppl.2): S235.Morgan T, Anderson A. Low dose combination therapy (perindopril, indapamide) compared with irbesartan monotherapy. J Hypertens 2001; 19 (Suppl.2): S235.Mogensen CE, Viberti G, Halimi S. Treatment based on a low dose combination of per-indopril and indapamide reduces albuminuria more effectively than enalapril in hyper-tensive type 2 diabetic patients. Am J Hypertens 2002; 15: 21A-2.Mogensen CE, Viberti G, Halimi S. Treatment based on a low dose combination of per-indopril and indapamide reduces albuminuria more effectively than enalapril in hyper-tensive type 2 diabetic patients. Am J Hypertens 2002; 15: 21A-2.De Luca N, Safar ME, Asmar R, et al. Efficacy of a very lowdose perindo-pril2mg/indapamide 0.625 mg on cardiac hypertrophy in hypertensive patients: the REASON project. J Hypertens 2002; 20 (Suppl. 4): S164.De Luca N, Safar ME, Asmar R, et al. Efficacy of a very lowdose perindo-pril2mg/indapamide 0.625 mg on cardiac hypertrophy in hypertensive patients: the REASON project. J Hypertens 2002; 20 (Suppl. 4): S164.Asmar RG, London GM, O’Rourke ME, et al. Improvement in blood pressure, arterial stiffness and wave reflections with a verylow-dose perindopril/indapamide combination in hypertensive patient. A comparison with atenolol. Hypertension 2001; 38: 922-6.Asmar RG, London GM, O’Rourke ME, et al. Improvement in blood pressure, arterial stiffness and wave reflections with a verylow-dose perindopril/indapamide combination in hypertensive patient. A comparison with atenolol. Hypertension 2001; 38: 922-6.Лопатин Ю.М., Иваненко В.В., Семенова Н.В. и др. Влияние фиксированной низкодозовой комбинации периндоприла/индапамида на процессы сердечно-сосудистого ремоделирования у ранее не леченных пациентов с артериальной гипертонией. Кардиология 2004; 5: 48-53.Лопатин Ю.М., Иваненко В.В., Семенова Н.В. и др. Влияние фиксированной низкодозовой комбинации периндоприла/индапамида на процессы сердечно-сосудистого ремоделирования у ранее не леченных пациентов с артериальной гипертонией. Кардиология 2004; 5: 48-53.The Seventh Report of the Joint National Committee on Prevention, Detection, Evalua-tion, and Treatment of High Blood Pressure. JAMA 2003; 289: 2560-72.The Seventh Report of the Joint National Committee on Prevention, Detection, Evalua-tion, and Treatment of High Blood Pressure. JAMA 2003; 289: 2560-72.Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Circulation 1977; 55: 613-8.Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Circulation 1977; 55: 613-8.

The authors declare that there are no conflicts of interest present.